Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results matching your filters

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative ColitisRecruiting
NCT07577856Phase 3Updated Jul 31, 2026
Sponsor: Janssen Research & Development, LLC
Colitis, Ulcerative
United States, Australia, Brazil, Canada, China +6 more
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal CancerRecruiting
NCT06662786Phase 3Updated Jul 31, 2026
Sponsor: Janssen Research & Development, LLC
Colorectal Neoplasms
United States, Belgium, Brazil, Canada, China +17 more
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's DiseaseRecruiting
NCT07499232Phase 3Updated Jul 31, 2026
Sponsor: Janssen Research & Development, LLC
Crohn Disease
United States, Austria, Belgium, Canada, China +12 more
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric PatientsRecruiting
NCT06690398Phase 3Updated Jul 31, 2026
Sponsor: Intra-Cellular Therapies, Inc.
Irritability Associated With Autism Spectrum Disorder
United States
A Long-term Extension (LTE) Study of Guselkumab in Pediatric ParticipantsRecruiting
NCT06663332Phase 3Updated Jul 31, 2026
Sponsor: Janssen Research & Development, LLC
Crohns Disease · Colitis, Ulcerative · Arthritis, Psoriatic · Arthritis, Juvenile
United States, Argentina, Australia, Brazil, China +11 more
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or AdalimumabRecruiting
NCT06100744Phase 3Updated Jul 31, 2026
Sponsor: AbbVie
Juvenile Psoriatic Arthritis
United States, Australia, Canada, France, Germany +4 more
Yulinzhu for Women With Diminished Ovarian ReserveRecruiting
NCT07550998Phase 3Updated Jul 31, 2026
Sponsor: The University of Hong Kong
Diminished Ovarian Reserve (DOR)
Hong Kong
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's DiseaseRecruiting
NCT07196722Phase 2, Phase 3Updated Jul 31, 2026
Sponsor: Janssen Research & Development, LLC
Crohn Disease
United States, Argentina, Australia, Belgium, Brazil +23 more
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With DapagliflozinRecruiting
NCT06677060Phase 3Updated Jul 31, 2026
Sponsor: AstraZeneca
Heart Failure
United States, Argentina, Australia, Brazil, Bulgaria +30 more
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder CancerRecruiting
NCT06919965Phase 3Updated Jul 31, 2026
Sponsor: Janssen Research & Development, LLC
Non-Muscle Invasive Bladder Neoplasms
United States, Argentina, Belgium, Brazil, China +10 more
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia SymptomsRecruiting
NCT06559306Phase 3Updated Jul 31, 2026
Sponsor: Janssen Research & Development, LLC
Depressive Disorder, Major
United States, Argentina, Brazil, Bulgaria, Colombia +11 more
A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other OptionRecruiting
NCT05179876Phase 3Updated Jul 31, 2026
Sponsor: Actelion
Hypertension, Pulmonary
Belarus, Belgium, Bulgaria, China, Hungary +8 more
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus ErythematosusRecruiting
NCT07438496Phase 3Updated Jul 31, 2026
Sponsor: Janssen Research & Development, LLC
Lupus Erythematosus, Systemic
United States, Argentina, Australia, Brazil, Bulgaria +24 more
A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)Recruiting
NCT05912517Phase 3Updated Jul 31, 2026
Sponsor: Janssen Research & Development, LLC
Hemolytic Disease of the Fetus and Newborn
United States, Argentina, Australia, Austria, Belgium +12 more
Extension Study for the Port Delivery System With Ranibizumab (Portal)Recruiting
NCT03683251Phase 3Updated Jul 31, 2026
Sponsor: Hoffmann-La Roche
Neovascular Age-Related Macular Degeneration
United States, Argentina, Australia, Austria, Belgium +10 more
A Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia GravisRecruiting
NCT06055959Phase 2, Phase 3Updated Jul 31, 2026
Sponsor: UCB Biopharma SRL
Generalized Myasthenia Gravis
United States, Italy, Poland, South Korea, United Kingdom
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's DiseaseRecruiting
NCT07577843Phase 3Updated Jul 31, 2026
Sponsor: Janssen Research & Development, LLC
Crohn Disease
United States, Australia, Brazil, Canada, Israel +4 more
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received ChemotherapyRecruiting
NCT06750094Phase 3Updated Jul 31, 2026
Sponsor: Janssen Research & Development, LLC
Colorectal Neoplasms
United States, Australia, Belgium, Brazil, China +21 more
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple MyelomaRecruiting
NCT07518186Phase 3Updated Jul 31, 2026
Sponsor: Janssen Research & Development, LLC
Multiple Myeloma
United States, Australia, China, France, Germany +10 more
A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)Recruiting
NCT07164443Phase 3Updated Jul 31, 2026
Sponsor: Janssen Research & Development, LLC
Metastatic Castration-resistant Prostate Neoplasms
United States, Australia, Belgium, Brazil, Canada +12 more
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)Recruiting
NCT05327114Phase 2, Phase 3Updated Jul 31, 2026
Sponsor: Janssen Research & Development, LLC
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
United States, Argentina, Australia, Canada, China +14 more
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell CarcinomaRecruiting
NCT07011719Phase 3Updated Jul 31, 2026
Sponsor: Arcus Biosciences, Inc.
Metastatic Clear Cell Renal Cell Carcinoma · Advanced Clear Cell Renal Cell Carcinoma
United States, Argentina, Australia, Canada, Czechia +11 more
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and ChemotherapyRecruiting
NCT03394365Phase 3Updated Jul 31, 2026
Sponsor: Pierre Fabre Medicament
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD) · Solid Organ Transplant Complications · Lymphoproliferative Disorders · Allogeneic Hematopoietic Cell Transplant
United States, Australia, Austria, Belgium, Canada +4 more
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder (ASD) in Pediatric PatientsRecruiting
NCT06706674Phase 3Updated Jul 31, 2026
Sponsor: Intra-Cellular Therapies, Inc.
Irritability Associated With Autism Spectrum Disorder
United States
Multi-Center Clean Air Randomized Controlled Trial in COPDRecruiting
NCT06376994Phase 3Updated Jul 31, 2026
Sponsor: JHSPH Center for Clinical Trials
Chronic Obstructive Pulmonary Disease (COPD)
United States

Previous page Next page